Deep Learning-Based Quantitative Plaque Composition Analysis Using Ex Vivo OCT-FLIm of Human Coronary Arteries

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Equity/Stock(s)/Options - Dotter</li><li>Royalty/Intellectual Property Rights - Dotter</li></ul>